Point72 (Difc) LTD Standard Biotools Inc. Transaction History
Point72 (Difc) LTD
- $2.64 Trillion
- Q2 2025
A detailed history of Point72 (Difc) LTD transactions in Standard Biotools Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 10,992 shares of LAB stock, worth $14,729. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,992Holding current value
$14,729% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$102 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$78.6 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.8 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.5 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $105M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...